Company
Y-mAbs
Bold Science, Innovative Medicines
Also known as Y-mAbs Therapeutics, Inc.
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2015
- Legal name
- Y-mAbs Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
At Y-mAbs Therapeutics, we develop and commercialize novel radioimmunotherapy and antibody-based therapies to treat some of the most challenging diseases.
About the company
- Status notes
- Y-mAbs is now part of SERB Pharmaceuticals.
Products
- Other
- DANYELZA® (naxitamab-gqgk)
Loading relationship preview